148 related articles for article (PubMed ID: 7783150)
21. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
22. 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
Pei XF; Gupta TH; Badio B; Padgett WL; Daly JW
J Med Chem; 1998 Jun; 41(12):2047-55. PubMed ID: 9622546
[TBL] [Abstract][Full Text] [Related]
23. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
[TBL] [Abstract][Full Text] [Related]
24. Autoradiographic analyses of agonist binding to muscarinic receptor subtypes.
Messer WS; Ellerbrock B; Price M; Hoss W
Biochem Pharmacol; 1989 Mar; 38(5):837-50. PubMed ID: 2564779
[TBL] [Abstract][Full Text] [Related]
25. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB
Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425
[TBL] [Abstract][Full Text] [Related]
27. Experimental localization of muscarinic receptor subtypes to cingulate cortical afferents and neurons.
Vogt BA; Burns DL
J Neurosci; 1988 Feb; 8(2):643-52. PubMed ID: 3339431
[TBL] [Abstract][Full Text] [Related]
28. Characterization of cholinergic muscarinic receptors in the rabbit iris.
Honkanen RE; Abdel-Latif AA
Biochem Pharmacol; 1988 Jul; 37(13):2575-83. PubMed ID: 3291881
[TBL] [Abstract][Full Text] [Related]
29. Different agonist binding properties of M1 and M2 muscarinic receptors in calf brain cortex membranes.
Vanderheyden P; Ebinger G; Vauquelin G
Biochem Pharmacol; 1987 Dec; 36(23):4119-24. PubMed ID: 3689439
[TBL] [Abstract][Full Text] [Related]
30. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.
Daly JW; Gupta TH; Padgett WL; Pei XF
J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
[TBL] [Abstract][Full Text] [Related]
32. Pharmacologic characterization of muscarinic receptors of insect brains.
Abdallah EA; Eldefrawi ME; Eldefrawi AT
Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028
[TBL] [Abstract][Full Text] [Related]
33. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
34. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
Lee W; Wolfe BB
Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
[TBL] [Abstract][Full Text] [Related]
35. Muscarinic receptor subtypes in rat pancreatic islets: binding and functional studies.
Verspohl EJ; Tacke R; Mutschler E; Lambrecht G
Eur J Pharmacol; 1990 Mar; 178(3):303-11. PubMed ID: 2187704
[TBL] [Abstract][Full Text] [Related]
36. Region-specific changes in CNS muscarinic acetylcholine receptors in a rat model of hyperammonemia.
Rukmini Devi RP; Murthy CR
Biochem Pharmacol; 1998 Jul; 56(2):237-41. PubMed ID: 9698078
[TBL] [Abstract][Full Text] [Related]
37. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
38. Bioisosteres of arecoline: 1,2,3,6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1,2,3-triazoles. Synthesis and muscarinic activity.
Moltzen EK; Pedersen H; Bøgesø KP; Meier E; Frederiksen K; Sánchez C; Løve Lembøl H
J Med Chem; 1994 Nov; 37(24):4085-99. PubMed ID: 7990109
[TBL] [Abstract][Full Text] [Related]
39. Muscarinic toxins from the venom of Dendroaspis snakes with agonist-like actions.
Jerusalinsky D; Kornisiuk E; Bernabeu R; Izquierdo I; Cerveñansky C
Toxicon; 1995 Apr; 33(4):389-97. PubMed ID: 7570625
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.
Dunbar PG; Durant GJ; Rho T; Ojo B; Huzl JJ; Smith DA; el-Assadi AA; Sbeih S; Ngur DO; Periyasamy S
J Med Chem; 1994 Aug; 37(17):2774-82. PubMed ID: 8064804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]